Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options (PRECODE): study protocol of a prospective, non-randomized, cohort study

Abstract Background Genomic profiling of advanced solid cancer in patients with no further evidence based standard treatment options is a novel approach to identify potential experimental treatment options based on specific genomic alterations. Due to the expected short survival of these patients ti...

Full description

Saved in:
Bibliographic Details
Main Authors: Karin Holmskov Hansen, Maria Bibi Lyng, Annette Raskov Kodahl, Jon Thor Asmussen, Arman Arshad, Henrik Petersen, Lotte Krogh, Sidse Ehmsen, Thomas Kielsgaard Kristensen, Henrik J. Ditzel
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Medical Genomics
Subjects:
Tumor agnostic therapy
Genomic profiling
Next generation sequencing
Solid cancers
Online Access:https://doi.org/10.1186/s12920-024-02033-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12920-024-02033-z

Similar Items